AZD2693 / AstraZeneca 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD2693 / AstraZeneca
2022-001629-65: A Study to Evaluate the Efficacy, Safety and Tolerability of AZD2693 given by subcutaneous injection in adult participants with non-cirrhotic nonalcoholic steatohepatitis with fibrosis and who have the PNPLA3 rs738409 148M Genetic Marker Studio per valutare l’efficacia, la sicurezza e la tollerabilità di AZD2693 somministrato come iniezione sottocutanea in pazienti adulti affetti da steatoepatite non alcolica non cirrotica (NASH) con fibrosi e portatori dell’allele di rischio di PNPLA3 rs738409 148M

Not yet recruiting
2
318
Europe
AZD2693, [AZD2693], Solution for injection/infusion
ASTRAZENECA AB, AstraZeneca AB
Non-cirrhotic non-alcoholic steatohepatitis with fibrosis Steatoepatite non alcolica non cirrotica con fibrosi, Non-alcoholic steatohepatitis Steatoepatite non alcolica, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
FORTUNA, NCT05809934 / 2022-001629-65: A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

Active, not recruiting
2
220
Europe, Japan, US, RoW
AZD2693, Placebo
AstraZeneca, AstraZeneca K.K.
Nonalcoholic Steatohepatitis
07/25
09/25
NCT05107336: Study to Assess the Safety, Tolerability, and Pharmacokinetics (Movement of Drugs Within the Body) of AZD2693 in Healthy Participants

Completed
1
44
Japan
AZD2693, Placebo
AstraZeneca
Healthy Participants
03/23
03/23
NCT04483947: A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients

Completed
1
74
US
AZD2693, Placebo
AstraZeneca, Parexel
Non-alcoholic Steatohepatitis (NASH)
12/23
12/23
NCT05919069: A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693

Completed
1
35
US
AZD2693
AstraZeneca
Hepatic Impairment
09/24
09/24

Download Options